COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry — Stella

Home/Myocarditis/

View on ClinicalTrials.gov

Recruiting

Back to Myocarditis trials

Trial locations(1 site)

Canada

University of Ottawa Heart Institute, Ottawa, Ontario

Key details

Sponsor

Ottawa Heart Institute Research Corporation

Enrollment target

~400 participants

Started

August 2021

Primary completion

December 2026

Age range

5 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.